**Core Concept:**
Glaucoma is a group of chronic eye diseases characterized by optic nerve damage and characteristic optic nerve head changes. The most common type is chronic simple (open angle) glaucoma, which results from elevated intraocular pressure due to a failure of the trabecular meshwork to drain aqueous humor.

**Why the Correct Answer is Right:**
In chronic simple (open angle) glaucoma, the elevated intraocular pressure causes damage to the optic nerve head, leading to optic disc cupping (enlargement of the optic disc) and enlargement of the blind spot. The goal of therapy is to lower intraocular pressure to prevent further optic nerve damage. The correct answer is A, **Timolol**, which is a beta-blocker. Beta-blockers are the first-choice medication for the treatment of open angle glaucoma due to their ability to lower intraocular pressure by reducing aqueous humor production and increasing outflow through the trabecular meshwork. Timolol is a topical, non-selective beta-blocker that acts on beta-1 receptors in the ciliary body, thereby reducing aqueous humor production and lowering intraocular pressure.

**Why Each Wrong Option is Incorrect:**

B. **Brimonidine**: This is another topical beta-blocker, but it is a selective alpha-2 agonist with beta-blocking properties, making it less effective for lowering intraocular pressure than non-selective beta-blockers like Timolol.

C. **Carbachol**: This is a topical cholinergic drug that increases aqueous humor production and exacerbates intraocular pressure, making it an unsuitable choice for glaucoma treatment.

D. **Amlodipine**: This is a calcium channel blocker indicated for hypertension treatment. It does not reduce intraocular pressure and is therefore not the correct medication for glaucoma management.

**Clinical Pearls:**

1. Glaucoma is a common cause of irreversible blindness in the elderly population. Early detection and treatment are crucial in preventing progression of the disease and vision loss.
2. Timolol is a non-selective beta-blocker that effectively lowers intraocular pressure by blocking beta-1 receptors in the ciliary body, leading to reduced aqueous humor production.
3. In the event of contraindications or adverse reactions to Timolol, a switch to another beta-blocker like Brimonidine or Carteolol can be considered.

Both Brimonidine and Carteolol are non-selective beta-blockers but have lower alpha-2 agonist activity than Timolol, allowing them to lower intraocular pressure more effectively.